ArticleJAAD case reports2026

CD30+ T-cell lymphoma following Chimeric Antigen Receptor T-cell therapy (CART-cell therapy): Diagnostic uncertainty in a postimmunotherapy setting.

Madison McClanahan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.